Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhongke Meiling Cryogenics CoBJSE:920992 61 5-Year Yield-on-Cost % is 0.75 as of Sep. 06, 2026, which is 3% above its 10-year median of 0.73. GuruFocus rates BJSE:920992 with a GF Score™ of 61/100 and a GF Value™ of ¥14.05 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Zhongke Meiling Cryogenics Co ranks worse than 81.85% on this metric.
The historical rank and industry rank for Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost % or its related term are showing as below:
BJSE:920992'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0.32 Med: 0.73 Max: 2.73
Current: 0.75
During the past 13 years, Zhongke Meiling Cryogenics Co's highest Yield on Cost was 2.73. The lowest was 0.32. And the median was 0.73.
BJSE:920992's 5-Year Yield-on-Cost % is ranked worse than 81.85% of 314
companies
in the Medical Devices & Instruments industry
Industry Median: 2.46
vs BJSE:920992: 0.75
Zhongke Meiling Cryogenics Co (BJSE:920992) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
Zhongke Meiling Cryogenics Co 5-Year Yield-on-Cost % Related Terms
BJSE:920992 vs ABT, SYK, MDT: 5-Year Yield-on-Cost % Comparison
For the Medical Devices subindustry, Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongke Meiling Cryogenics Co 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost % falls into.
Zhongke Meiling Cryogenics Co 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
Zhongke Meiling Cryogenics Co (BJSE:920992) has a 5-Year Yield-on-Cost % of 0.75 as of Sep. 06, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Zhongke Meiling Cryogenics Co and its competitors. This is near median its historical median of 0.73. Over the past decade, Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost % has ranged from 0.32 to 2.73. According to the industry distribution chart, Zhongke Meiling Cryogenics Co ranks #257 out of 314 companies in the Medical Devices & Instruments industry, placing it in the top 81.8%.
Is Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost % too high?
Zhongke Meiling Cryogenics Co's current 5-Year Yield-on-Cost % of 0.75 is near median its 10-year median of 0.73. Over the past 10 years, this metric has ranged from a low of 0.32 to a high of 2.73. The Medical Devices & Instruments industry median 5-Year Yield-on-Cost % is 2.46. Zhongke Meiling Cryogenics Co's value of 0.75 is 69.5% below this industry median. Based on the distribution chart, Zhongke Meiling Cryogenics Co ranks #257 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Zhongke Meiling Cryogenics Co has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zhongke Meiling Cryogenics Co's 5-Year Yield-on-Cost % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Zhongke Meiling Cryogenics Co ranks #257 out of 314 companies for 5-Year Yield-on-Cost %. This places Zhongke Meiling Cryogenics Co in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.46. Zhongke Meiling Cryogenics Co's value of 0.75 is 69.5% below this benchmark. Historically, Zhongke Meiling Cryogenics Co's own 5-Year Yield-on-Cost % has ranged from 0.32 to 2.73 over the past decade. While the company's 10-year median is 0.73 vs. the industry median of 2.46, Zhongke Meiling Cryogenics Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.46, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zhongke Meiling Cryogenics Co's current 5-Year Yield-on-Cost % of 0.75 is 69.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on Zhongke Meiling Cryogenics Co and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongke Meiling Cryogenics Co's current 5-Year Yield-on-Cost % is 0.75, which is near median its own 10-year median of 0.73. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongke Meiling Cryogenics Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co (BJSE:920992) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.05, compared to a current price of ¥11.95 — trading 14.9% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.75, which is near median its 10-year median of 0.73 and 69.5% below the Medical Devices & Instruments industry median of 2.46. Zhongke Meiling Cryogenics Co's overall GF Score™ is 61/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For Zhongke Meiling Cryogenics Co (BJSE:920992), the current 5-Year Yield-on-Cost % is 0.75 as of Sep. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongke Meiling Cryogenics Co (BJSE:920992) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongke Meiling Cryogenics Co stock appears to be undervalued.
The current stock price of ¥11.95 is trading 14.9% below its estimated GF Value™ of ¥14.05.
GuruFocus considers Zhongke Meiling Cryogenics Co to be Modestly Undervalued.
Key valuation signals for BJSE:920992:
5-Year Yield-on-Cost %: 0.75 (near median its 10-year median of 0.73)
GF Value™: ¥14.05 vs. price of ¥11.95 (14.9% below fair value)
Industry Position: 69.5% below the Medical Devices & Instruments median (#257 of 314)
No single metric tells the full story. See the BJSE:920992 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongke Meiling Cryogenics Co Ltd engages in research and development, production, and sales of biomedical cryogenic storage equipment. The company's main products include a lab / medical refrigerator and freezer, ultra-low temperature freezer, blood bank refrigerator, inventory rack/box, professional cold room, and bio-bank management.
61GF Score
Get the complete analysis for BJSE:920992
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920992 has been successfully added to your 
